| . | ICa density . | ICa density . | Transient amplitude . | Transient amplitude . | SR Ca2+ content . |
|---|---|---|---|---|---|
| −40/−25 mV (pA/pF) | −40/0 mV (pA/pF) | −40/−25 mV (ΔF/F0) | −40/0 mV (ΔF/F0) | (ΔF/F0) | |
| WT (N = 5/n = 11) | |||||
| Control | 0.44 ± 0.16 | 4.83 ± 0.43 | 0.45 ± 0.09 | 2.23 ± 0.29 | 2.84 ± 0.29 |
| Iso | 1.98 ± 0.61a | 8.73 ± 0.95a | 1.09 ± 0.23a | 2.47 ± 0.36a | 2.96 ± 0.35 |
| S2030A (N = 5/n = 11) | |||||
| Control | 0.89 ± 0.39 | 6.87 ± 0.43b | 1.04 ± 0.13b | 2.93 ± 0.16b | 4.46 ± 0.25b |
| Iso | 2.93 ± 0.93a | 10.82 ± 1.23a | 1.01 ±0.14 | 2.3 ± 0.19 | 4.51 ± 0.24 |
| . | ICa density . | ICa density . | Transient amplitude . | Transient amplitude . | SR Ca2+ content . |
|---|---|---|---|---|---|
| −40/−25 mV (pA/pF) | −40/0 mV (pA/pF) | −40/−25 mV (ΔF/F0) | −40/0 mV (ΔF/F0) | (ΔF/F0) | |
| WT (N = 5/n = 11) | |||||
| Control | 0.44 ± 0.16 | 4.83 ± 0.43 | 0.45 ± 0.09 | 2.23 ± 0.29 | 2.84 ± 0.29 |
| Iso | 1.98 ± 0.61a | 8.73 ± 0.95a | 1.09 ± 0.23a | 2.47 ± 0.36a | 2.96 ± 0.35 |
| S2030A (N = 5/n = 11) | |||||
| Control | 0.89 ± 0.39 | 6.87 ± 0.43b | 1.04 ± 0.13b | 2.93 ± 0.16b | 4.46 ± 0.25b |
| Iso | 2.93 ± 0.93a | 10.82 ± 1.23a | 1.01 ±0.14 | 2.3 ± 0.19 | 4.51 ± 0.24 |
ICa and transients were measured in freshly isolated ventricular cardiomyocytes of WT and S2030A+/+ knock-in mice. Peak ICa was recorded at different membrane potentials (from −40 to 0 mV or −25 to 0 mV) in control conditions (1.8 mM [Ca2+]o) and during 100 nmol/liter Iso application. The protocol shown in Fig. S2 was used to experimentally match the SR Ca2+ content between control and Iso in all cells. At matched SR Ca2+ load, the Ca2+ release in S2030A+/+ myocytes did not increase during Iso, suggesting a decreased RyRs sensitivity (see Fig. 1). Data are expressed as means ± SEM of n measurements.
P < 0.05 versus control.
P < 0.05 versus WT.